CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.

about

CD44 drives aggressiveness and chemoresistance of a metastatic human osteosarcoma xenograft model.

Item

http://www.wikidata.org/entity/Q48511799

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@en

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@nl

type

Item

label

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@en

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@nl

prefLabel

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@en

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@nl

P1476

CD44 drives aggressiveness and ...... osteosarcoma xenograft model.

@en

P2093

Bernd Kubista

http://www.w3.org/2001/XMLSchema#string

Daniela Lötsch

http://www.w3.org/2001/XMLSchema#string

Lisa Mayr

http://www.w3.org/2001/XMLSchema#string

Sushilla Van Schoonhoven

http://www.w3.org/2001/XMLSchema#string

P2860

The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer

Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells

Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer

Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer

The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells

Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup.

Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.

Guidelines for the welfare and use of animals in cancer research.

CD44 staining of cancer stem-like cells is influenced by down-regulation of CD44 variant isoforms and up-regulation of the standard CD44 isoform in the population of cells that have undergone epithelial-to-mesenchymal transition.

P304

114095-114108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.23125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29371972

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5768389

http://www.w3.org/2001/XMLSchema#string